BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 33114183)

  • 21. Associated changes of lipid peroxidation and transforming growth factor beta1 levels in human colon cancer during tumour progression.
    Biasi F; Tessitore L; Zanetti D; Cutrin JC; Zingaro B; Chiarpotto E; Zarkovic N; Serviddio G; Poli G
    Gut; 2002 Mar; 50(3):361-7. PubMed ID: 11839715
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transforming growth-factor-Beta - a cytokine with multiple actions in oncology and potential clinical-applications (review).
    Kekow J; Wiedemann G
    Int J Oncol; 1995 Jul; 7(1):177-82. PubMed ID: 21552824
    [TBL] [Abstract][Full Text] [Related]  

  • 23. microRNA and non-canonical TGF-β signalling: implications for prostate cancer therapy.
    Ottley E; Gold E
    Crit Rev Oncol Hematol; 2014 Oct; 92(1):49-60. PubMed ID: 24985060
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of transforming growth factor beta in cancer.
    Pasche B
    J Cell Physiol; 2001 Feb; 186(2):153-68. PubMed ID: 11169452
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression profiling of genes regulated by TGF-beta: differential regulation in normal and tumour cells.
    Ranganathan P; Agrawal A; Bhushan R; Chavalmane AK; Kalathur RK; Takahashi T; Kondaiah P
    BMC Genomics; 2007 Apr; 8():98. PubMed ID: 17425807
    [TBL] [Abstract][Full Text] [Related]  

  • 26. TGF-β induced chemoresistance in liver cancer is modulated by xenobiotic nuclear receptor PXR.
    Bhagyaraj E; Ahuja N; Kumar S; Tiwari D; Gupta S; Nanduri R; Gupta P
    Cell Cycle; 2019 Dec; 18(24):3589-3602. PubMed ID: 31739702
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Response of prostate cancer cells to peptide growth factors: transforming growth factor-beta.
    Wilding G
    Cancer Surv; 1991; 11():147-63. PubMed ID: 1841749
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of transforming growth factor β in T helper 17 differentiation.
    Zhang S
    Immunology; 2018 Sep; 155(1):24-35. PubMed ID: 29682722
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mesenchymal stromal cells (MSCs) and colorectal cancer: a troublesome twosome for the anti-tumour immune response?
    O'Malley G; Heijltjes M; Houston AM; Rani S; Ritter T; Egan LJ; Ryan AE
    Oncotarget; 2016 Sep; 7(37):60752-60774. PubMed ID: 27542276
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hitting More Birds with a Stone: Impact of TGF-β on ILC Activity in Cancer.
    Fionda C; Stabile H; Cerboni C; Soriani A; Gismondi A; Cippitelli M; Santoni A
    J Clin Med; 2020 Jan; 9(1):. PubMed ID: 31948072
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transforming growth factor β: A potential biomarker and therapeutic target of ventricular remodeling.
    Ma Y; Zou H; Zhu XX; Pang J; Xu Q; Jin QY; Ding YH; Zhou B; Huang DS
    Oncotarget; 2017 Aug; 8(32):53780-53790. PubMed ID: 28881850
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The transcription factor GLI2 as a downstream mediator of transforming growth factor-β-induced fibroblast activation in SSc.
    Liang R; Šumová B; Cordazzo C; Mallano T; Zhang Y; Wohlfahrt T; Dees C; Ramming A; Krasowska D; Michalska-Jakubus M; Distler O; Schett G; Šenolt L; Distler JH
    Ann Rheum Dis; 2017 Apr; 76(4):756-764. PubMed ID: 27793816
    [TBL] [Abstract][Full Text] [Related]  

  • 33. TGF-β in T Cell Biology: Implications for Cancer Immunotherapy.
    Dahmani A; Delisle JS
    Cancers (Basel); 2018 Jun; 10(6):. PubMed ID: 29891791
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structure, function and possible clinical application of transforming growth factor-beta.
    Miyazono K; Heldin CH
    J Dermatol; 1992 Nov; 19(11):644-7. PubMed ID: 1293145
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Does TGF-β induced formation of actin stress fibres reinforce Smad dependent TGF-β signalling in the prostate?
    Assinder S; Cole N
    Med Hypotheses; 2011 Jun; 76(6):802-4. PubMed ID: 21421289
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Perspective on the Development of TGF-β Inhibitors for Cancer Treatment.
    Huynh LK; Hipolito CJ; Ten Dijke P
    Biomolecules; 2019 Nov; 9(11):. PubMed ID: 31744193
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Smad7: not only a regulator, but also a cross-talk mediator of TGF-β signalling.
    Yan X; Chen YG
    Biochem J; 2011 Feb; 434(1):1-10. PubMed ID: 21269274
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Crosstalk between the TGF-β and WNT signalling pathways during cardiac fibrogenesis.
    Działo E; Tkacz K; Błyszczuk P
    Acta Biochim Pol; 2018; 65(3):341-349. PubMed ID: 30040870
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A crucial function of PDGF in TGF-beta-mediated cancer progression of hepatocytes.
    Gotzmann J; Fischer AN; Zojer M; Mikula M; Proell V; Huber H; Jechlinger M; Waerner T; Weith A; Beug H; Mikulits W
    Oncogene; 2006 May; 25(22):3170-85. PubMed ID: 16607286
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stromal Modulators of TGF-β in Cancer.
    Costanza B; Umelo IA; Bellier J; Castronovo V; Turtoi A
    J Clin Med; 2017 Jan; 6(1):. PubMed ID: 28067804
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.